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Abstract: Michael addition of aldehydes to nitro-olefins is an effective method 
to obtain useful chiral γ-nitroaldehydes. γ-Nitroaldehydes are precursors for 
chiral γ-aminobutyric acid analogues, which have numerous pharmacological 
activities and are used for the treatment of neurological disorders. A whole-cell 
system based on recombinantly expressed 4-oxalocrotonate tautomerase 
(4-OT) was developed and shown to be an effective biocatalyst for the Michael 
addition of branched aldehydes to β-nitrostyrenes. The aim of this study was to 
investigate the influence of the substitution of the N-terminal proline with 
lysine and arginine, both containing a reactive ε-amino group, on the Michael 
addition catalyzed by 4-OT. First, the effects of these mutations were examined 
by in silico analysis, followed by the generation of three terminal lysine mut-
ants. The generated mutants, 4-OT_K, 4-OT_PK and 4-OT_KK were tested for 
their ability to utilise β-nitrostyrene (1), (E)-1-nitro-2-(2-thienyl)ethene (2) and 
trans-p-chloro-β-nitrostyrene (3) as Michael acceptors with isobutanal 
(2-methylpropanal) as the donor. For comparison, the lithium salt of lysine was 
used in the same organocatalytic reactions. In general, the introduction of lys-
ine had a negative effect on Michael additions based on overall product yields. 
However, additional lysine residues at the N-terminus of the protein resulted in 
structural changes that enhanced the activity towards 2 and 3. Therefore, the 
N-terminal proline is important for 4-OT-catalysed Michael-additions, but it is 
not essential. 
Keywords: 4-oxalocrotonate tautomerase, biocatalysis, organocatalysis, lysine, 
mutagenesis. 
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INTRODUCTION 
The enzyme 4-oxalocrotonate tautomerase (4-OT) is member of tautomerase 
superfamily with a unique catalytic N-terminal proline.1,2 It is encoded by the 
xylH gene and is a part of an aromatic hydrocarbon degradation pathway in 
Pseudomonas putida mt-2. It catalyzes the conversion of 2-hydroxy-2,4-hexa-
dienedioate to 2-oxo-3-hexenedioate.3 In addition to its natural activity, 4-OT, 
when utilised as a free enzyme catalyses the isomerisation of cis-nitrostyrene to 
trans-nitrostyrene,4 aldol condensations,5 dehydrations, and Michael-type addi-
tions of acetaldehyde to β-nitrostyrene.6 Michael-type reactions are widely util-
ised reactions for the formation of C–C bonds in general, and nitrostyrenes are 
highly active Michael acceptors that are often used in these type of reactions.7–9 
Michael-type addition of aldehydes to a variety of nitro-olefins is an effective 
method to obtain useful chiral γ-nitroaldehydes.6,10–12 γ-Nitroaldehydes are pre-
cursors for chiral γ-aminobutyric acid analogues,13 which have numerous phar-
macological activities including antidepressant, anticonvulsant, anxiolytic, anti- 
-emetic and other activities.13,14 
Based on D2O exchange and X-ray crystallography studies, it was revealed 
that the promiscuous activity of 4-OT relies on the deprotonation of acetaldehyde 
by the N-terminal proline and by the formation of enamine species between 
them.15 Therefore, it is reasonable to propose that the reaction involving isobut-
anal proceeds via the same mechanism (Scheme 1A). Proline is unique because it 
is the only amino acid where the side chain is connected to the α-amino group, 
forming a five-membered nitrogen-containing ring, which makes proline an 
imino acid (Scheme 1B). It is aliphatic and hydrophobic, and has preference for a 
turn structure and can usually be found on the protein surface. The proline side-
chain is non-reactive and due to the restricted dihedral angles, it can adopt in the 
polypeptide chain, it is rarely involved in the active site of an enzyme.16 Proline 
 
Scheme 1. A) Formation of the enamine intermediate in a Michael-type reaction and  
B) 3D structures and charges at physiological pH of the amino acids of interest  
(proline, lysine and arginine). 
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can sometimes be substituted with other small amino acids, although its unique 
properties limit the possible substitutions. Lysine and arginine are positively 
charged polar amino acids (Scheme 1B). They frequently play an important role 
in protein structure and are involved in salt-bridges, where they pair with a neg-
atively charged amino acid to create a stabilizing form.16 They are quite frequent 
in the active site of enzymes, because the positively charged ε-amino group on 
their side-chain is sometimes involved in electrostatic interactions. 
A whole-cell system based on recombinantly expressed 4-OT has been dev-
eloped in our laboratory and shown to be an effective biocatalyst for the asym-
metric Michael addition of acetaldehyde and different branched aldehydes to 
β-nitrostyrenes.11,17 Two mutants, one with an additional N-terminal proline 
(4-OT_P), as well as a variant with two substituted amino acids with proline, 
namely Ala3Pro and Gln4Pro (4-OT_2P), were generated and their activities 
assesed.17 This study focuses on the effect of the substitution of the Pro1 of 4-OT 
(terminal proline (Pro1)) with basic amino acids containing ε-amino groups, 
namely lysine and arginine, through in silico analysis followed by generation of 
three specific 4-OT variants containing lysine. 4-OT variants were assessed for 
the ability to utilise β-nitrostyrene (1), (E)-1-nitro-2-(2-thienyl)ethene (2) and 
trans-p-chloro-β-nitrostyrene (3) as Michael acceptors with isobutanal as the 
Michael donor (Scheme 2). Additionally, an organocatalyst based on the lithium 
salt of lysine was prepared and utilized in the same reactions for an adequate 
comparison. 
 
Scheme 2. Michael-type addition of isobutanal to substrate(s) 1–3 catalysed by whole-cell 
Escherichia coli BL21 (DE3) expressing 4-oxalocrotonate tautomerase, obtaining respective 
products 4–6. 
EXPERIMENTAL 
Reagents 
β-Nitrostyrene, (E)-1-nitro-2-(2-thienyl)ethane, trans-p-chloro-β-nitrostyrene, isobutanal, 
and all other chemicals were of analytical grade and purchased from Sigma–Aldrich (Munich, 
Germany). Ethyl acetate, ethanol and other solvents were of HPLC reagent grade and pur-
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chased from Fisher Scientific (Hampton, NH, USA). Petrol ether (b.p. 50–70 °C) was 
purchased from Reahem, Novi Sad, Serbia. 
The QuikChange® site-directed mutagenesis kit was purchased from Stratagene (La Jolla, 
CA, USA). The QIA-prep spin plasmid mini-prep kit was purchased from QIAGEN (Hilden, 
Germany). The BigDye® Terminator v1.1 Cycle Sequencing Kit was purchased from Applied Bio-
systems and primers from Invitrogen, both part of ThermoFisher Scientific (Foster City, CA, 
USA). 
Ampicillin, isopropyl-β-D-1-thiogalactopyranoside (IPTG), and other salts and reagents 
were purchased from Sigma–Aldrich (Munich, Germany). Glucose, tryptone, yeast extract, 
casamino acids and other media components were purchased either from Oxoid (Cambridge, 
UK) or Becton Dickinson (Sparks, MD, USA). 
4-OT molecular modelling 
Mutated positions in the 4-oxalocrotonate tautomerase (4-OT) protein were mapped onto 
the available crystal structure (pdb code 1BJP) and the hexamer was formed according to the 
biologically active form of 4-OT. The protein structure was refined using the energy minimiz-
ation script in CNS. Docking of substrate was performed in AutoDock Tools and Vina, figures 
were prepared in PyMol (The PyMOL Molecular Graphics System, Version 1.4.1., Schrodinger, 
LLC). 
Mutagenesis 
The recombinant Escherichia coli BL21(DE3) strain expressing 4-oxalocrotonate tauto-
merase was previously constructed and maintained in the laboratory.17 Mutants were gene-
rated using the QuikChange® site-directed mutagenesis kit according to manufacturer’s ins-
tructions using appropriate primers (Table I) for the introduction of single mutations. New 
plasmids were transformed into E. coli BL21(DE3). The recombinant plasmids were isolated 
and construct DNAs were verified by sequencing (Table I) using Applied Biosystems 3130 
genetic analyzer (ThermoFisher Scientific, Foster City, CA, USA). The BLASTN program 
(NCBI, http://www.ncbi.nlm.nih.gov18) was used for sequence similarity searches. 
TABLE I. Oligonucleotide primers and E. coli strains used in this study 
Primers or recombinant 
E. coli strain Relevant characteristics 
Source or 
reference 
Primers (5′–3′) 
TAUT_ins_P_K 
TAUT_inf_P_K 
TAUT_inf_K_ins_P_K 
TAUTR 
T7R_seq 
ATACATATGAAGATTGCCCAGATC 
ATACATATGAAGCCTATTGCCCAGATC 
ATACATATGAAGAAGCCTATTGCCCAGATC 
GATCTGGGCAATCTTCATATGTAT 
GCTAGTTATTGCTCAGCGG 
This work 
This work 
This work 
This work 
Invitrogen 
Recombinant E. coli 
BL21(DE3) 
BL21(4-OT) 
BL21(4-OT_K) 
BL21(4-OT_KP) 
BL21(4-OT_KK) 
F-, ompT, T7 promoter regulated expression 
expressing pRSET-TAUT 
expressing pRSET-TAUT_K 
expressing pRSET-TAUT_KP 
expressing pRSET-TAUT_KK 
Invitrogen 
[17] 
This work 
This work 
This work 
For culture propagation, Luria–Bertani (LB) or M9 minimal medium was used.19 M9 
medium was supplemented with casamino acids (5 g L-1 and 50 µg mL-1 of ampicillin was 
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routinely used to select for ampicillin resistance (ampR). Stock cultures of all strains were 
maintained at –80 °C in LB with glycerol (200 g L-1). 
Biocatalyst preparation and biocatalytic reactions 
The whole-cell biocatalyst system containing wild type or mutated 4-OT was prepared as 
described previously, using M9 minimal medium supplemented with casamino acids (5 g L-1) 
and ampicillin (50 µg mL-1).17 Once the culture had reached an optical density of 0.5 (600 
nm; spectrophotometer Ultrospec 3300pro, Amersham Biosciences, Little Chalfont, United 
Kingdom), the cells were induced with 0.1 mM IPTG at 28 °C. After 12 h expression, the 
cells were harvested by centrifugation at 5000g for 10 min in an Eppendorf 5804R bench top 
centrifuge. The wet cell pellets were resuspended to a concentration of cell dry weight (CDW) 
of 5 g L-1 (OD = 20) in 20 mM Na2HPO4 buffer, pH 7.2. 
Unless otherwise stated, nitroalkenes 1–3 were added sequentially as described pre-
viously17 to a final concentration of 2 mM (18 mg) from a 200 mM stock solution in ethanol 
(1) or 2-butanol (2 and 3) and isobutanal was added to a final concentration of 20 mM. 
Samples (100 µL) were withdrawn from the reaction over time, centrifuged at 13000g for 5 
min and the supernatants were analyzed spectrophotometrically as previously described, 
following the depletion of 1 by reduction of absorbance at 320 nm (ε = 14.4 mM-1 cm-1).5 
Depletion of substrates 2 and 3 were monitored by TLC.11 The products were extracted and 
purified from the reaction mixture with ethyl acetate (2×20 mL). The combined organic 
extract was washed with brine (20 mL), and dried over anhydrous MgSO4. After filtration and 
removal of the solvent under reduced pressure, the residue was purified by dry flash column 
chromatography (silica gel), eluting with petroleum ether–ethyl acetate mixture in a gradient 
(from 7:3 to 9:1) to obtain the pure nitroaldehydes. 
Organocatalysis using L-lysine lithium salt 
The general procedure for the synthesis of γ-nitroaldehydes from the corresponding alde-
hydes catalysed by L-lysine lithium salt (LysOLi) was realised using reported procedures.20,21 
Analytical methods (HPLC) and characterization of γ-nitroaldehydes 
The NMR spectra were recorded on a Varian Gemini 200 (1H-NMR at 200 MHz, in 
deuterated chloroform). The NMR data are given in the Supplementary material to this paper. 
The chemical shifts are expressed in ppm (δ) using tetramethylsilane as an internal standard; 
the coupling constants (J) are in Hz.  
RESULTS AND DISCUSSION 
Previously, a whole-cell system based on recombinantly expressed 4-OT 
originating from Pseudomonas putida mt-2 was described and shown to be an 
effective biocatalyst for asymmetric Michael addition of acetaldehyde to β-nitro-
styrene.17 In addition, the biocatalytic strategy was extended by showing that this 
biocatalyst also accepts various substituted aromatic and heterocyclic nitroal-
kenes as acceptors and branched aldehydes as donors.11 The aim was to inves-
tigate the influence of substitution of the Pro1 of 4-OT with basic amino acid(s) 
lysine and/or arginine, having reactive ε-amino groups that could make enamines 
with branched aldehydes, on the efficiency of the Michael-type reaction (Scheme 
2). Moroz and co-workers reported that the introduction of a highly reactive 
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residue into calmodulin, which does not have catalytic activity, converts its 
74-residue-long C-terminal domain into an efficient esterase.23  
Protein modelling 
Changes to the N-terminal residue of 4-OT influence the catalytic activity of 
the enzyme since the N-terminus participates in the active site and enamine inter-
mediate formation (Scheme 1A and Fig. 1A).17 Protein modelling with β-nitro-
styrene as substrate was performed in order to see how substitutions would inf-
luence the protein conformation. Replacing the N-terminal Pro1 with Lys1 part-
ially changes the size of the binding pocket (Fig. 1B). The surface charge, how-
ever, remains the same since the side chain ε-amino group takes the position of 
the terminal amino group of the original proline residue due to conformational 
change of the N-terminal part of the protein. Replacing the N-terminal Pro1 with 
Arg1 adds more positive charge to the binding pocket, but also further shrinks the 
active site, influencing the conformation of the surrounding residues and blocks 
access to the binding pocket (Fig. 1C). One important role of lysine and arginine 
in proteins is the formation of electrostatic interactions, which make the protein 
more stable, but they could also form electrostatic interactions with other non-
protein molecules.16  
 
Fig. 1. Surface representation of the binding pocket with the respective N-terminal residue 
denoted; A) wild type 4-OT with docked nitrostyrene (NYST), B) 4-OT_K mutant with lysine 
instead of proline and C) 4-OT_R mutant with arginine blocking the access 
to the binding pocket. 
The effect of the arginine on protein activity was shown by Sokalingam and 
co-workers in the mutagenesis of lysine to arginine, where they observed that this 
mutation affected protein folding, which decreases the productivity of functional 
mutants.24 This might be a consequence of the guanidinium group of arginine, 
which allows interactions in three possible directions, and allows arginine to 
form a large number of electrostatic interactions.16 In the case of the Arg1 mut-
ant of 4-OT where active site is small, the arginine makes interactions that block 
the active site. Based on the results of protein modelling, it was decided to per-
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form mutations with lysine and make three mutants, substituted Pro1 with Lys  
(4-OT_K), add lysine in front of the proline (4-OT_KP) and added lysine to the 
lysine substituted Pro1 (4-OT_KK). It is worth noting that during in silico anal-
ysis the possibility of the presence of the initial methionine from the recom-
binantly expressed protein was not taken into consideration. Methionine excision 
usually happens during the posttranslational tailoring of the proteins due to the 
presence of methionine aminopeptidases in the expression strain. This process is 
highly dependent on the penultimate N-terminal residue of its substrate. The 
results obtained show that the extent of excision decreased with increasing size of 
the introduced second amino acid.24–27 
Organocatalytic reactions with substrates 1–3 
Organocatalytic reactions were conducted with LysOLi as the catalyst and 
control reactions with phenylalanine lithium salt (PheOLi) as the catalyst. The 
reaction mixtures were stirred for 5 days at room temperature for organocatalysis 
with Lys, while a shorter time was needed when Phe was used as the catalyst. 
The asymmetric organocatalytic approach with the lithium salt of lysine and 
CH2Cl2 as the reaction medium yielded 21, 54 and 5 % of products 4–6, respect-
ively (Table II). In comparison with the control reactions with PheOLi, the yields 
of the products with LysOLi were lower, except when 3 was used as the sub-
strate, when LysOLi yielded 5 % of product 6 while no reaction occurred with 
PheOLi. Considering that lysine is an α-amino acid and has an ε-amino group 
that often participates in hydrogen bonding and as a general base in catalysis, 
this amino acid could easily form an enamine species with branched aldehydes.  
TABLE II. Yield of reaction products 4–6 obtained with organocatalysis and biocatalysis with 
wild-type 4-OT and terminal lysine mutants 
Product Organocatalysis yield, mg Biocatalysis yield, mg LysOLi PheOLi 4-OT_K 4-OT_PK 4-OT_KK 4-OT_wt 
4 5.6 13.86 9.33 8.76 7.69 15.93 
5 16.57 23.93 6.44 15.95 17.18 10.43 
6 1.36 NA 2.99 4.64 7.36 4.91 
This might be the reason why the reaction occurred with substrate 3, 
although the product yield was very low, while no reaction was observed when 
Phe was used as the catalyst. Lower product yield when 1 and 2 were used as 
substrates in the reactions with LysOLi could be attributed to the structural 
differences of the substrates. 
Biotransformation of 1–3 with 4-OT wild type biocatalyst and 4-OT lysine mutants 
All biocatalytic reactions were performed with the wild-type and the three 
lysine mutants with 1–3 as the Michael acceptors and isobutyraldehyde as the 
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Michael donor. All reactions were performed for 18 h, except in the case with 
wild type 4-OT biocatalyst and β-nitrostyrene (1), when the reaction was com-
plete within 4 h.  
 
Fig. 2. Surface representation of the binding pocket of the wild type and lysine mutants; 
A) wild type with docked nitrostyrene (NYST), B) 4-OT_K mutant , C) 4-OT_PK mutant and 
D) 4-OT_KK mutant. 
When β-nitrostyrene (1) was used as the substrate, the wt biocatalyst per-
formed the best because the overall reaction time was 4.5 times shorter than the 
reactions when mutants were used as biocatalysts. In addition, the product yield 
was around 2 times greater when wt 4-OT was used as the biocatalyst (Table II). 
However, in comparison with the organocatalytic reaction with the lithium salt of 
lysine, biocatalysis was better considering the reaction time and product yield, 
showing 6 and 1.5 times improvement, respectively. In the case of substrate 1, all 
mutations had a negative effect on the enzyme activity. The effect of the gener-
ated mutations was assessed by protein modelling experiments in which β-nitro-
styrene was used as the substrate. Replacing the N-terminal proline with lysine 
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partially changes the size of the binding pocket (Fig. 2B). Adding another lysine 
residue to the N-terminus of the polypeptide chain significantly shortens the size 
of the binding pocket, thereby influencing possible interaction of ligands with 
Arg39 28 but keeping the net positive charge of the binding pocket (Fig. 2C). 
Mutation of Pro1 to Lys1 and addition of lysine to the N-terminus had obvious 
consequences on the binding pocket by adding a positive charge to the previously 
hydrophobic bottom of the active site (Fig. 2D), thereby influencing the binding 
behaviour of the ligands. In addition, the added N-terminal lysine (as is the case 
with 4-OT_PK) decreases the active site cavity and disturbs possible interactions 
with Arg39. 
Although, lysine is found frequently in active sites because of its positively 
charged ε-amino group that can form electrostatic interactions,16 this mutation 
had a negative effect on the activity of 4-OT in reactions with substrate 1. How-
ever, the reaction still proceeded indicating that Pro1 is important, but not essen-
tial for the 4-OT activity in the Michael-type addition of isobutanal to β-nitro-
styrene. This is also supported by previously obtained results on the N-terminal 
proline-enriched mutants, namely 4-OT_P and 4-OT_2P, because the activity of 
the 4-OT_2P mutant was lower, while 4-OT_P had a similar activity to wild type 
4-OT, when 1 was used as the substrate.17 
When (E)-1-nitro-2-(2-thienyl)ethene (2) was used as the Michael donor, the 
least efficient was the 4-OT_K mutant yielding 21 % of product 5. The organo-
catalyst LysOLi and the mutants 4-OT_PK and 4-OT_KK showed similar effic-
iency, yielding 54, 52 and 56 % of product 5, respectively, while wt 4-OT 
yielded 34 % of product 5 (Table II). The lysine mutations had a positive influ-
ence on the biocatalyst activity when 2 was used as the Michael acceptor. 
In the case when trans-p-chloro-β-nitrostyrene (3) was used as the substrate, 
the lowest amount of product 6 was obtained in the organocatalysis with LysOLi 
(5 %), while in the reaction with PheOLi, no product could be isolated. It was 
shown that electron-withdrawing substituents at the aromatic ring of β-nitro-
styrene are poor Michael acceptors and influence the reaction time.17 The 
4-OT_KK mutant performed the best in comparison to reactions when 4-OT, 
4-OT_PK and 4-OT_KK were used as biocatalysts, yielding 1.5, 2.5 and 1.6 
times more product 6, respectively (Table II). 
CONCLUSIONS 
During this study, the effect of the substitution of the terminal proline with 
lysine on the promiscuous activity of 4-OT was assessed. Changing Pro1 to Lys1 
was not favourable for any of the substrates tested, as the mutant 4-OT_K needed 
more time to perform the reactions in comparison to wild type 4-OT and the pro-
duct yield was lower. An additional lysine, as in 4-OT_PK mutation, did not inf-
luence the efficiency of the biocatalyst in Michael-type reactions, because the 
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substrate yield indicated that this efficiency was under the influence of the nature 
of the substrates. In the case when 4-OT was changed from Pro1 to Lys1 and an 
additional lysine was incorporated (4-OT_KK mutant), there was a positive 
effect on an enzyme activity when substrates 2 and 3 were used, but not when 
substrate 1 was used. Since generated mutants showed a slight improvement in 
activity using substrates 2 and 3, it could be concluded that Pro1 is important, but 
not essential for the promiscuous Michael-type activity of 4-OT. The results 
suggest that future studies should be directed towards rational redesign of pro-
teins exhibiting promiscuous activity in order to improve or change their select-
ivity towards certain substrates. 
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И З В О Д  
ЗНАЧАЈ АМИНО-ТЕРМИНАЛНОГ ПРОЛИНА ЗА НЕСПЕЦИФИЧНУ  
АКТИВНОСТ 4-ОКСАЛОКРОТОНАТ-ТАУТОМЕРАЗЕ (4-ОТ) 
ЈЕЛЕНА ЛАЗИЋ1,2, JЕЛЕНА СПАСИЋ1, ЂОРЂЕ ФРАНЦУСКИ1, ЗОРАНА ТОКИЋ-ВУJОШЕВИЋ3,  
ЈАСМИНА НИКОДИНОВИЋ-РУНИЋ1, ВЕСЕЛИН МАСЛАК2 и ЛИДИЈА ЂОКИЋ1 
1Институт за молекуларну генетику и генетичко инжењерство, Универзитет у Београду,  
Војводе Степе 444а, Београд, 2Хемијски факултет, Универзитет у Београду, Студентски трг 12–16, 
Београд и 3Фармацеутски факултет, Универзитет у Београду, Војводе Степе 450, Београд 
Реакција Мајклове адиције алдехида на нитроолефине представља ефикасну 
методу синтезе хиралних γ-нитроалдехида, прекурсорa аналога хиралне γ-аминобутерне 
киселине који се користе у терапијама неуролошких обољења. Целе бактеријске ћелије 
са хетеролого експримираном 4-оксалокротонат-таутомеразом (4-OT) показале су се 
као веома ефикасни биокатализатори у Мајкловој адицији рачвастих алдехида на β-нит-
ростирене. Циљ овог рада био је да се испита утицај замене амино-терминалног пролина 
аминокиселинама са реактивном ε-амино групом, као што су лизин или аргинин, на 
механизам реакције Мајклове адиције. Ефекат ових мутација је анализиран in silico, а 
потом су конструисани мутанти са лизином на амино терминусу. Тестирана је способ-
ност мутаната 4-OT_K, 4-OT_PK и 4-OT_KK да користе β-нитростирен (1), (E)-1-нитро-2- 
-(2-тиенил)оетен (2) и trans-p-хлор-β-нитростирен (3) као Мајклове акцепторе, и изобу-
танал као донор. Литијумова со лизина је коришћена у органокатализи са истим суп-
стратима ради поређења. Увођење лизина на амино терминус протеина имало је нега-
тиван ефекат на Мајклову адицију, јер су приноси производа реакција смањени. Дода-
вање лизина утицало je на структурне промене 4-ОТ чиме је побољшана активност овог 
ензима када су 2 и 3 коришћени као супстрати. Сходно томе може се закључити да је 
терминални пролин важан за активност 4-ОТ али не и кључан. 
(Примљено 22. фебруара, ревидирано 15. априла, прихваћено 27. априла 2016) 
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